54
In band
Moving averages
SMA 200$186.08+16.10%
Company profile
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.
SectorHealthcare
IndustryDrug Manufacturers - General
Market cap$31.12B
P/E ratio37.02
EPS$5.69
Beta0.162
Dividend yield0.00%
52-week high$219.72
52-week low$131.52
Similar stocks in Drug Manufacturers - General
RSI alerts for BIIB
Get an email the moment Biogen Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 15 August 2026 at 6:16 AM EDT